# Prophylactic Effect of Nirmatrelvir/Ritonavir and Ursodeoxycholic Acid on Reducing Complications After Cardiac Surgery

> **NCT05690646** · PHASE4 · UNKNOWN · sponsor: **China National Center for Cardiovascular Diseases** · enrollment: 491 (actual)

## Conditions studied

- Cardiac Surgery

## Interventions

- **DRUG:** Nirmatrelvir/ritonavir
- **DRUG:** Ursodeoxycholic acid

## Key facts

- **NCT ID:** NCT05690646
- **Lead sponsor:** China National Center for Cardiovascular Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-28
- **Primary completion:** 2023-03-24
- **Final completion:** 2026-01-06
- **Target enrollment:** 491 (ACTUAL)
- **Last updated:** 2023-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05690646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05690646, "Prophylactic Effect of Nirmatrelvir/Ritonavir and Ursodeoxycholic Acid on Reducing Complications After Cardiac Surgery". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05690646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*